Workload Planning: Frequently Asked Questions – Part 2
Beth Harper of Clinical Performance Partners continues to answers questions posed during her recent webinar on workload planning in clinical trials.
Workload Planning: Frequently Asked Questions – Part 1
Beth Harper of Clinical Performance Partners answers questions posed during her recent webinar on workload planning in clinical trials.
Onsemble Conference Provides Building Blocks for Clinical Research Operations
Brian Brake, Research Compliance Coordinator at IU and first-time attendee at the Onsemble 2013 Spring Conference, shares his experience.
Onsemble Members Inspire and Contribute to Clinical Research Blog
Onsemble conferences provide tremendous value to the clinical research community. What if we could all take a piece of Onsemble with us all year long?
Site Selection for Sponsored Trials: How You Can Rank at the Top
The Hoosier Oncology Group, a leading CRO, shares tips for setting your research institution apart from the rest and becoming a “go-to” site.
Disclosure Requirements for ClinicalTrials.gov: Your FAQs Answered (Part 2)
Barbara Godlew, of The FAIRE Company, LLC, answers your questions related to ClinicalTrials.gov. This is the second part of a two-part series.
CTMS and EMR Software: Why Integration is Necessary
It must be an industry priority to collaborate in order to integrate electronic health record systems with clinical trial management systems.
Subject Reimbursement in Clinical Trials: When and How?
Trial participants often complete things that likely would not be requested with routine care. When and how to compensation subjects is often debated.
Consortia in Clinical Trials: Do the Benefits Outweigh the Challenges?
The concept of conducting clinical trials in a consortium is gaining greater prominence in the industry. Beverly Ginsburg-Cooper, Senior VP for Research at Dana-Farber Cancer Institute, discusses the benefits and lessons learned at the Dana-Farber/Harvard Cancer Center.
Disclosure Requirements for ClinicalTrials.gov: Your FAQs Answered (Part 1)
Barbara Godlew, President of The FAIRE Company, answers your questions on disclosure requirements for ClinicalTrials.gov. Part 1 of a 2-part series.
Patient Retention: Minimize Dropout Rates Simply and Effectively
Since recruitment alone can be a long, tedious, and costly activity, it is critical that enrolled subjects maintain their participation for the duration of the trial.
Reducing Turnover of Study Coordinators at Clinical Research Sites
In my experience as a Clinical Research Associate, I’ve observed the working patterns of CRCs, and I’m not surprised by the high attrition rate.